ÂÜÀòÂÒÂ×

Sean Donnelly serves as the Chief Executive Officer of IPM - Integrated Prescription Management since April 2023, overseeing all strategy and operations for the organization and its executive team. Positioned as a Board Member at Altus Biologics since April 2018 and previously as CEO, Donnelly managed a significant acquisition and directed operations across various healthcare sectors. Prior experience includes roles at Waud Capital Partners as Operating Executive, and a lengthy tenure at Express Scripts where responsibilities spanned multiple leadership positions, including President of the Commercial Division with comprehensive P&L accountability. Donnelly began a career in consulting at EY, providing strategic support across diverse industries. Both Bachelor of Business Administration degrees in Management Information Systems were earned at the University of Notre Dame.